NCT05218629 2023-03-29Anlotinib Plus PD-1 Inhibitor as 2nd-line Threapy in Patients With Metastatic Pancreatic CancerQingdao Central HospitalPhase 2 Unknown20 enrolled
NCT04050787 2019-08-08Spleen-Preserving No. 10 Lymph Node Dissection in Gastric CancerThe First Hospital of Jilin UniversityPhase NA Unknown100 enrolled